Psychedelics Are Going Mainstream. Investing in Them Hasn’t.
Psychedelics spent a half-century in political and medical purgatory. Now they’re starting to go mainstream. Respected academic institutes and billionaires ...
Saturday, April 18, 2026
Tag: Mental Disorders
A Surprising Beneficiary of New Alzheimer’s Drugs: GE HealthCare
Biogen, Eli Lilly drugs will expand the imaging market for companies in the diagnostics space.
Alzheimer’s Blockbuster Is Coming, but Slowly
Developers of Alzheimer’s drugs have work cut out for them getting the treatments to patients.
Eli Lilly Results Signal Arrival of Blockbuster New Drug Class
ShareListen(2 min)
EDITOR'S PICK
EP NEWSROOM
© 2025 Edinburg Post or its affiliated companies.